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Rotavirus genotype G12 strains were detected for the first time among newborns with asymptomatic
rotavirus infection (74% of 39 rotavirus strains isolated from the infected infants were genotype G12) in the
nursery of the All India Institute of Medical Sciences during a period from 2005 to 2006. Sequence analysis of
the VP7 genes from these neonatal strains indicated a high level of homology to other G12 strains reported
worldwide, suggesting the recent emergence of these strains in humans. Such nosocomial infections of new-
borns represent a potential source of introduction of novel rotavirus serotypes into the community.
Each year, rotavirus (RV) accounts for an estimated 100,000
deaths and 400,000 hospitalizations in children5 years of age
in India and 454,000 to 705,000 deaths worldwide (13). The
accelerated development and introduction of an RV vaccine
have become a global health priority, and two vaccines have
been recently licensed and may soon address this problem
(1). At the same time, two neonatal RV strains are being
developed as vaccine candidates because preliminary studies
indicate that they are well adapted to the neonatal gut,
induce systemic and mucosal immune responses, and protect
children against severe RV-induced diarrhea upon reinfec-
tion (2–4, 10).
Our previous report on an outbreak of asymptomatic RV
infection at the All India Institute of Medical Sciences
(AIIMS), New Delhi, in 1985, as well as the multicenter sur-
veillance study conducted from 1986 to 1993, demonstrated
that two novel strains, G9P[11], a human-bovine reassortant
strain, and G9P[6], were common causes of infections in the
hospital nurseries in Delhi (2, 6). Since then, no further sur-
veillance of RV infection in newborns has been conducted. Yet
knowledge of circulating RV strains in local populations is
important for the development and evaluation of new candi-
date vaccines, and early warning of the emergence of novel
strains may help in the establishment of a follow-up strategy
that may be useful in future vaccine development. RV strains
infecting neonates may be a source of emergence of new
strains that subsequently spread into the community. For ex-
ample, novel strains of genotype P[6] were found worldwide in
newborns years before the P[6] strains were identified as a
cause of diarrhea in older children (7, 11). In this study, a
decade after our previous survey examining newborns, we
again conducted surveillance in the nursery at AIIMS to see if
neonatal RV strains related to 116E or any other RV strains
were present in the nursery.
Fecal specimens were collected twice during days 2 to 9 after
birth from all the neonates born during the period from Sep-
tember 2005 to August 2006 at the AIIMS nursery in New
Delhi, India. RV testing of the stool was performed using a
monoclonal antibody-based enzyme immunoassay kit (Premier
Rotaclone; Meridian Biosciences, Cincinnati, OH). Neonates
were considered to be infected with RV if at least one of the
stool samples was positive for the virus. RV double-stranded
RNA was extracted from stools or laboratory strains by the
TRIzol (Invitrogen Corp., Carlsbad, CA) method, and the RNA
was used for polyacrylamide gel electrophoresis and the determi-
nation of the G and P types of the strains by reverse transcrip-
tion-PCR (6). Genotyping was initially performed using com-
mon G (G1 to G4 and G9) and P (P4, P6, P8, and P11) type
primers in a multiplex assay (3). After initially detecting nu-
merous nontypeable strains, we subsequently included a G12-
specific primer in the oligonucleotide pool for the G-typing
PCR assay (18). Nucleotide sequencing of a fragment of the
VP7 gene of strains that could not be typed with primers for
common strains (G1 to G4 and G9) was performed using a
previously described method (18). Multiple sequence align-
ments of the VP7 gene sequences (spanning nucleotides [nt] 68
to 580) of these strains with the equivalent regions of genotype
G12 sequences from the GenBank database were carried out
using CLUSTAL W 1.81 as described previously (19). Dis-
tances were calculated using the Kimura two-parameter
method, and a dendrogram was constructed using the neigh-
bor-joining method with MEGA software, version 2.1 (19).
In this survey, RV antigens were detected in 16% of neo-
nates (39 of 245) born during this period. Although surveil-
lance was conducted for 1 year, the dates of isolation of the
majority of the RV isolates (21 of 39) clustered in January and
February 2006 (Fig. 1). Most RVs (34 of 39) were detected in
newborns between 5 and 9 days of age.
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Our analysis of the G and P genotypes of strains from all 39
RV-infected neonates yielded the following results: 28 of 39
strains (72%) were originally nontypeable, 6 of 39 (15%) were
G9, 4 of 39 (10%) had mixed G types, and 1 was identified as
a G2 strain. All of the strains had P[6] VP4 specificity. Nucle-
otide sequencing of 513-bp VP7 gene fragments (spanning nt
68 to 580) from four nontypeable strains identified them as
genotype G12 based on the high degree of homology of the
sequences to those of G12 strains listed in the GenBank data-
base. Subsequently, using reverse transcription-PCR with G12
primers, we found that 21 of 24 remaining nontypeable strains
were also G12, and samples from the remaining 3 newborns
were exhausted. Interestingly, the G12P[6] strain was also de-
tected in all four cases of mixed infections, making the total
number of G12 strains 29 (74% of the total).
An analysis of the VP7 gene nucleotides of G12 strains (n 
4) by using a distance matrix demonstrated 89 to 99% ho-
mology to those of other human G12 strains reported world-
wide. The maximum homology was observed with G12 strains
from Calcutta and strain Se585 from the United States (data
not shown). A phylogenetic analysis using MEGA version 2.1
confirmed the close relationship to recent G12 isolates from
many countries (Fig. 2). Polyacrylamide gel electrophoresis
analysis of RV genomic double-stranded RNA identified a
single RNA migration pattern (electropherotype) for 30 of the
39 strains examined (data not shown). The amount of RNA in
the remaining strains was insufficient for visualization by silver
staining.
We previously reported that asymptomatic RV infection in
neonates at AIIMS conferred protection against severe diar-
rhea upon reinfection (2). Based on this observation, the vac-
cine candidate 116E (type G9P[11]) has been developed and is
presently being evaluated in clinical trials (3). After a decade,
we reinitiated surveillance with the aim of determining
whether closely related strains were still present among neo-
nates in the nursery. During the period from September 2005
to August 2006, a large number of neonates born in the AIIMS
nursery were found to be infected with RV. However, the
observed rate of RV detection was much lower than that in our
previous study (16 versus 73%) (2). Unlike the previous study,
this survey did not detect any G9P[11] (116E-like) strains (2).
Instead, G12P[6], a recently emerging strain among children
with diarrhea worldwide, was detected for the first time in a
nursery outbreak among asymptomatic newborns in New Delhi
(3, 14, 16, 18, 20, 21). This finding reinforces the hypothesis
that some novel strains of RV may emerge in newborns whose
high titers of maternal antibody to common strains select for
strains that contain novel serotype antigens. In a recent study,
Ray and Kelkar observed that low titers of neutralizing anti-
bodies to common strains (e.g., G1, G2, G4, and G9) among
the mothers predisposed the children to infection with those
serotypes (17). In another study, Ramachandran et al. noted
that low titers of neutralizing antibodies to strain 116E in cord
blood predisposed newborns to infection with 116E-like strains
(15). In the present study, we detected G12P[6] infections
concomitantly with a low incidence of G9P[6] strains. Since
G9P[6] strains have been circulating in the Delhi community
for the past several years, we hypothesize that preexisting im-
munity among neonates in the form of maternal antibodies to
these strains and lower titers of antibodies to G12 may explain
these results. In the future, it will be interesting to test titers of
G12-specific neutralizing antibodies in the mothers or in the
cord blood of the babies infected with these strains to further
examine this hypothesis.
The original source of the G12 RV and the mechanism of its
introduction into the AIIMS nursery are unknown. The un-
usual G9P[11] strains previously introduced at AIIMS had a
probable bovine origin (8), as indicated by a close relationship
FIG. 1. Seasonal distribution and percent prevalence of VP7 genotypes of neonatal RV strains detected during the period from 2005 to 2006
at the AIIMS nursery. *, includes G2 strains, strains involved in mixed infections, and nontypeable strains.
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FIG. 2. Neighbor-joining dendrogram of the VP7 gene (nt 68 to 580) of neonatal G12 RV strains from AIIMS (shown in boldface) and other
G12 strains. Reference sequences were obtained from the GenBank and EMBL databases; accession numbers are given in parentheses.
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with the VP4 gene of a bovine P[11] RV. Since P[11] strains of
various serotypes are common in India, we speculated that
introduction by members of the hospital staff or mothers ad-
mitted to the nursery or by other mechanisms was possible.
G12 strains have been found in animals from India (9), so a
mechanism of introduction into the nursery similar to that of
the G9P[11] strains may be operative. For both the earlier
P[11] strains and the present G12 isolates, introduction may
have been followed by reassortment with other nursery strains.
In addition, since the animal P[11] and G12 gene homologues
are significantly divergent from those of G9P[11] and G12P[6]
isolates at AIIMS, either the evolution of the VP7 or VP4 gene
to its present-day form occurred or other progenitors are yet to
be discovered. Further analysis and comparison of these strains
both from the nursery and from the community may reveal
their relatedness and may help in understanding the evolution
and origin of G12 RVs.
The identical electropherotypes of all G12 RV strains in-
fecting neonates in the present study suggested a common
source of nosocomial infection. A similar observation was also
made in our earlier study on neonatal RV infections, which
demonstrated a point-source nosocomial infection with a sin-
gle strain (G9P[11]) that persisted for several years at AIIMS.
RV strains infecting neonates have been hypothesized to rep-
resent a possible source of emergence of new strains that
subsequently spread in the local community. Previously, G8 or
G9 strains that were found to be prevalent in hospital nurseries
have also been identified in the community (5, 6, 10, 12).
Globally, P[6] strains were distinctly labeled as neonatal
strains because they were identified in newborns in Sweden,
the United Kingdom, Venezuela, and Australia (4, 7). Se-
quence analyses demonstrated that the corresponding commu-
nity and neonatal strains were virtually identical; in the case of
G9, the newborn strains were identified 2 years earlier than the
community strains, and P[6] strains are now commonly found
in older children with diarrhea. The high degree of sequence
homology among G12 strains from India and those worldwide
also indicates the recent emergence of these strains in the
populations or alternatively suggests that we should next ex-
pect to find G12 strains in the Delhi population of older chil-
dren with RV diarrhea.
In conclusion, G9P[11], a strain previously prevalent in ne-
onates, is no longer present in the AIIMS nursery, while
G12P[6], which has been recently detected at a high frequency
in diarrheal children worldwide, was detected for the first time
among asymptomatic neonates, also at a high frequency. This
finding supports previous observations that newborns are sen-
sitive hosts for novel strains of RV whose outer capsid pro-
teins, VP4 and VP7, are not neutralized by high titers of
circulating maternal antibodies. Selected surveillance of new-
borns for RV in settings where nosocomial infections are com-
mon may provide an early discovery of new strains that may
later enter routine circulation in older children.
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